APA (7th ed.) Citation

SL, C., M, B., A, M., P, K., C, G., L, G., . . . M, R. (2000). Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours. British journal of cancer, 83(12), 1599. https://doi.org/10.1054/bjoc.2000.1503

Chicago Style (17th ed.) Citation

SL, Cheeseman, Brannan M, McGown A, Khan P, Gardner C, Gumbrell L, Dickens D, and Ranson M. "Phase I and Pharmacologic Study of CT-2584 HMS, a Modulator of Phosphatidic Acid, in Adult Patients with Solid Tumours." British Journal of Cancer 83, no. 12 (2000): 1599. https://doi.org/10.1054/bjoc.2000.1503.

MLA (9th ed.) Citation

SL, Cheeseman, et al. "Phase I and Pharmacologic Study of CT-2584 HMS, a Modulator of Phosphatidic Acid, in Adult Patients with Solid Tumours." British Journal of Cancer, vol. 83, no. 12, 2000, p. 1599, https://doi.org/10.1054/bjoc.2000.1503.